Abstract:Abstract Recent advances in genome-wide DNA methylation (DNAm) profiling for smoking behaviour have given rise to a new, molecular biomarker of smoking exposure. It is unclear whether a smoking-associated DNAm (epigenetic) score has predictive value for ageing-related health outcomes which is independent of contributions from self-reported (phenotypic) smoking measures. Blood DNA methylation levels were measured in 895 adults aged 70 years in the Lothian Birth Cohort 1936 (LBC1936) study using the Illumina 450K assay. A DNA methylation score based on 230 CpGs was used as a proxy for smoking exposure. Associations between smoking variables and health outcomes at age 70 were modelled using general linear modelling (ANCOVA) and logistic regression. Additional analyses of smoking with brain MRI measures at age 73 ( n = 532) were performed. Smoking-DNAm scores were positively associated with self-reported smoking status ( P < 0.001, eta-squared ɳ 2 = 0.63) and smoking pack years ( r = 0.69, P < 0.001). Higher smoking DNAm scores were associated with variables related to poorer cognitive function, structural brain integrity, physical health, and psychosocial health. Compared with phenotypic smoking, the methylation marker provided stronger associations with all of the cognitive function scores, especially visuospatial ability ( P < 0.001, partial eta-squared ɳ p 2 = 0.022) and processing speed ( P < 0.001, ɳ p 2 = 0.030); inflammatory markers (all P < 0.001, ranges from ɳ p 2 = 0.021 to 0.030); dietary patterns (healthy diet ( P < 0.001, ɳ p 2 = 0.052) and traditional diet ( P < 0.001, ɳ p 2 = 0.032); stroke ( P = 0.006, OR 1.48, 95% CI 1.12, 1.96); mortality ( P < 0.001, OR 1.59, 95% CI 1.42, 1.79), and at age 73; with MRI volumetric measures (all P < 0.001, ranges from ɳ p 2 = 0.030 to 0.052). Additionally, education was the most important life-course predictor of lifetime smoking tested. Our results suggest that a smoking-associated methylation biomarker typically explains a greater proportion of the variance in some smoking-related morbidities in older adults, than phenotypic measures of smoking exposure, with some of the accounted-for variance being independent of phenotypic smoking status.

Age-related gene expression changes, and transcriptome wide association study of physical and cognitive aging traits, in the Lothian Birth Cohort 1936

A Serum Mirna Profile of Human Longevity: Findings from the Baltimore Longitudinal Study of Aging (BLSA)

EPIGENETIC PROFILES OF BIOLOGICAL AGING HALLMARKS

Attitudes to ageing, biomarkers of ageing and mortality: the Lothian Birth Cohort 1936

Epigenetic signatures of smoking associate with cognitive function, brain structure, and mental and physical health outcomes in the Lothian Birth Cohort 1936

Genetic regulation of gene expression and splicing during a 10-year period of human aging

Polygenic predictors of age-related decline in cognitive ability

Aging is associated with a systemic length-associated transcriptome imbalance

Epigenetic measures of ageing predict the prevalence and incidence of leading causes of death and disease burden

An Atlas of the Aging Lung Mapped by Single Cell Transcriptomics and Deep Tissue Proteomics

Life-course exposure to air pollution and biological ageing in the Lothian Birth Cohort 1936

A genome-wide association study of aging

Socioeconomic position, lifestyle habits and biomarkers of epigenetic aging: a multi-cohort analysis

Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging

Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging

Epigenome-wide association study of leukocyte telomere length.

Lung tissue gene-expression signature for the ageing lung in COPD

Investigation of genetic determinants of cognitive change in later life

Integrative epigenetics and transcriptomics identify aging genes in human blood

Transcriptomic analysis of elderly women with low muscle mass: association with immune system pathway

Multivariate investigation of aging in mouse models expressing the Alzheimer's protective APOE2 allele: integrating cognitive metrics, brain imaging, and blood transcriptomics